Department of Pediatric Surgery, Linyi Central Hospital, Linyi, China.
Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5172-5179. doi: 10.26355/eurrev_201808_15713.
We explored the regulation of miR-429 in nephroblastoma cells, investigating the mechanisms by which miR-429 influenced the proliferation and apoptosis of nephroblastoma.
The quantitative reverse transcription polymerase chain reaction (qRT-PCR) was conducted to detect the expression of miR-429 in nephroblastoma tissues and cell lines (G401). The interaction between miR-429 and c-myc was confirmed by qRT-PCR, Western blotting and luciferase assays, respectively. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and clone formation assay were used to detect the effect of miR-429 on the proliferation and clone formation ability of G401 cells. Cell cycle and apoptosis of G401 cells were measured by flow cytometry and TUNEL staining, respectively.
miR-429 was down-regulated in nephroblastoma tissues and cells. On-line target gene prediction software was applied to screen c-myc, the potential downstream target gene of miR-429. The expression of c-myc was negatively regulated by miR-429. Subsequent experiments demonstrated that overexpression of miR-429 inhibited the proliferation ability and arrested cell cycle of G401 cells in G0/G1 phase. Besides, the number of apoptotic cells was increased in miR-429 intervened group. However, c-myc could reverse the biological effects of miR-429 on proliferation, apoptosis, clone formation and cell cycle of G401 cells.
MiR-429 can regulate the proliferation, clone formation, cell cycle and apoptosis of nephroblastoma cells through targeting c-myc, indicating miR-429 may function as a potential therapeutic target for the treatment of nephroblastoma.
本研究旨在探讨 miR-429 对肾母细胞瘤细胞增殖和凋亡的调控作用及其机制。
采用实时定量逆转录聚合酶链反应(qRT-PCR)检测 miR-429 在肾母细胞瘤组织和细胞系(G401)中的表达。应用 qRT-PCR、Western blot 和荧光素酶报告基因实验分别验证 miR-429 与 c-myc 的相互作用。MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐)和克隆形成实验检测 miR-429 对 G401 细胞增殖和克隆形成能力的影响。流式细胞术和 TUNEL 染色分别检测 G401 细胞周期和凋亡。
miR-429 在肾母细胞瘤组织和细胞中呈低表达。在线靶基因预测软件筛选出 c-myc 是 miR-429 的潜在下游靶基因。miR-429 对 c-myc 的表达具有负调控作用。后续实验表明,过表达 miR-429 可抑制 G401 细胞的增殖能力,并将细胞周期阻滞在 G0/G1 期。此外,miR-429 干预组的凋亡细胞数量增加。然而,c-myc 可逆转 miR-429 对 G401 细胞增殖、凋亡、克隆形成和细胞周期的生物学效应。
miR-429 可通过靶向 c-myc 调控肾母细胞瘤细胞的增殖、克隆形成、细胞周期和凋亡,提示 miR-429 可能成为治疗肾母细胞瘤的潜在靶点。